Your browser is no longer supported. Please, upgrade your browser.
Settings
NVIV InVivo Therapeutics Holdings Corp. daily Stock Chart
NVIV [NASD]
InVivo Therapeutics Holdings Corp.
Index- P/E- EPS (ttm)-8.46 Insider Own0.10% Shs Outstand9.69M Perf Week-5.87%
Market Cap6.25M Forward P/E- EPS next Y-0.93 Insider Trans0.00% Shs Float9.30M Perf Month-14.23%
Income-21.30M PEG- EPS next Q-0.31 Inst Own12.40% Short Float1.21% Perf Quarter-56.14%
Sales- P/S- EPS this Y76.90% Inst Trans- Short Ratio1.50 Perf Half Y-59.19%
Book/sh1.45 P/B0.44 EPS next Y17.70% ROA-105.50% Target Price4.60 Perf Year-68.08%
Cash/sh- P/C- EPS next 5Y- ROE-184.10% 52W Range0.61 - 2.75 Perf YTD-57.30%
Dividend- P/FCF- EPS past 5Y38.30% ROI- 52W High-76.55% Beta1.43
Dividend %- Quick Ratio6.90 Sales past 5Y- Gross Margin- 52W Low5.70% ATR0.07
Employees6 Current Ratio6.90 Sales Q/Q- Oper. Margin- RSI (14)34.35 Volatility8.25% 10.18%
OptionableNo Debt/Eq0.00 EPS Q/Q99.70% Profit Margin- Rel Volume0.54 Prev Close0.65
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout- Avg Volume74.87K Price0.64
Recom- SMA20-10.43% SMA50-26.82% SMA200-56.69% Volume40,569 Change-0.80%
Jul-31-17Downgrade Raymond James Outperform → Mkt Perform
May-05-17Downgrade Raymond James Strong Buy → Outperform
Jul-21-16Initiated Ladenburg Thalmann Buy
Jul-07-16Initiated Raymond James Strong Buy $13
Jul-16-19 08:00AM  InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord Business Wire
Jul-12-19 08:00AM  InVivo Therapeutics Announces Postponement of Annual Meeting Business Wire
Jun-14-19 08:00AM  InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire
May-29-19 02:54PM  Bob Langer-founded device-maker InVivo starts new trial after patient deaths American City Business Journals -5.41%
08:00AM  InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury Business Wire
Apr-17-19 08:00AM  InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury Business Wire
Apr-01-19 08:15AM  InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update Business Wire
Jan-14-19 08:00AM  InVivo Therapeutics Announces Appointment of Richard Christopher as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Nov-29-18 08:00AM  InVivo Therapeutics to Present at the LD Micro Main Event on Tuesday December 4th, 2018 Business Wire
Nov-19-18 09:00AM  Report: Developing Opportunities within Command Center, Neurotrope, Selecta Biosciences, InVivo Therapeutics, SeaSpine, and Senestech Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-08-18 06:55PM  InVivo: 3Q Earnings Snapshot Associated Press
04:30PM  InVivo Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business Update Business Wire
Oct-02-18 08:00AM  InVivo Therapeutics Announces Joint Research Collaboration with Q Therapeutics, Inc. Business Wire
Oct-01-18 08:00AM  InVivo Therapeutics Announces Publication of Neuro-Spinal Scaffold Preclinical Data in Peer-Reviewed Journal Biomaterials Business Wire
Sep-28-18 08:05AM  InVivo Therapeutics Announces Presentation at the Ladenburg Thalmann 2018 Healthcare Conference and Provides Business Update Business Wire
Aug-28-18 08:00AM  InVivo Therapeutics Announces Complete 12-Month Data from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury Business Wire
Aug-07-18 07:42PM  InVivo: 2Q Earnings Snapshot Associated Press
04:30PM  InVivo Therapeutics Reports 2018 Second Quarter Financial Results Business Wire
Jun-25-18 04:05PM  InVivo Therapeutics Announces Closing of $15.2 Million Public Offering, Including the Exercise of Underwriters Overallotment Option Business Wire
Jun-21-18 09:00AM  InVivo Therapeutics Announces Pricing of $13.2 Million Underwritten Public Offering Business Wire -44.51%
May-24-18 10:35AM  Is InVivo Therapeutics Holdings Corps (NASDAQ:NVIV) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
May-07-18 06:44PM  InVivo: 1Q Earnings Snapshot Associated Press +6.55%
04:30PM  InVivo Therapeutics Reports 2018 First Quarter Financial Results Business Wire
Apr-18-18 08:20AM  Todays Research Reports on Stocks to Watch: vTv Therapeutics and InVivo Therapeutics ACCESSWIRE -9.26%
Apr-09-18 08:00AM  InVivo Therapeutics Provides Business Update Business Wire -30.27%
Mar-19-18 08:00AM  InVivo Therapeutics Announces Contemporary Thoracic SCI Registry Study (the CONTEMPO Registry Study) Findings Business Wire -7.47%
Mar-12-18 08:35AM  InVivo reports 4Q loss Associated Press -7.61%
08:15AM  InVivo Therapeutics Reports 2017 Year-end Financial Results Business Wire
Mar-09-18 10:34AM  Is It Time To Buy InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)? Simply Wall St. -7.72%
08:20AM  Todays Research Reports on Stocks to Watch: Johnson & Johnson and InVivo Therapeutics ACCESSWIRE
Mar-08-18 08:00AM  InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold in Patients with Acute Spinal Cord Injury Business Wire +49.37%
Feb-05-18 08:00AM  InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and Chief Executive Officer Business Wire
Jan-29-18 07:00AM  Blog Exposure - InVivo Therapeutics Signs Share Repurchase Agreement with Lincoln Park Capital ACCESSWIRE -13.42%
Jan-26-18 08:00AM  InVivo Therapeutics Announces Purchase Agreement for up to $15 Million with Lincoln Park Capital Business Wire
Jan-03-18 08:00AM  InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward Business Wire -21.43%
Dec-18-17 08:00AM  InVivo Therapeutics Announces Executive Management and Board Changes Business Wire
Nov-06-17 08:00AM  InVivo Therapeutics to Present at Canaccord Genuitys Medical Technologies & Diagnostics Forum Business Wire
Oct-30-17 06:03PM  InVivo reports 3Q loss Associated Press
04:45PM  InVivo Therapeutics Provides Business Update and Reports 2017 Third Quarter Financial Results Business Wire
Oct-11-17 10:14AM  What Is InVivo Therapeutics Holdings Corps (NVIV) Share Price Doing? Simply Wall St.
Oct-10-17 08:00AM  InVivo Therapeutics Announces Oral Platform Presentation at 2017 Congress of Neurological Surgeons Annual Meeting Business Wire
Sep-20-17 08:00AM  InVivo Therapeutics to Present at Ladenburg Thalmann 2017 Healthcare Conference Business Wire
Sep-05-17 08:00AM  InVivo Therapeutics Announces Publication in Neurosurgery of Lifetime Hospitalization Costs for Thoracic Spinal Cord Injury Patients by Severity Grade Business Wire
Aug-29-17 05:59PM  InVivo slashes staff and ousts science chief American City Business Journals
Aug-28-17 04:30PM  InVivo Therapeutics Announces Strategic Corporate Restructuring Business Wire
Aug-10-17 09:00AM  InVivo Therapeutics Announces Exchange of Certain Warrants for Common Stock Business Wire -30.00%
Aug-09-17 11:37PM  InVivo reports 2Q loss Associated Press
Aug-08-17 06:00PM  InVivo Therapeutics Provides Business Update and Reports 2017 Second Quarter Financial Results Business Wire -10.00%
08:00AM  InVivo Therapeutics to Present at Canaccord Genuitys 37th Annual Growth Conference Business Wire
Aug-01-17 08:00AM  Today's Research Reports on Stocks to Watch: InVivo Therapeutics Holdings and Dynavax Technologies ACCESSWIRE -5.56%
Jul-31-17 12:46PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of InVivo Therapeutics Holding Corp. (NVIV) PR Newswire -26.53%
11:23AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of InVivo Therapeutics Holding Corp. - NVIV ACCESSWIRE
09:45AM  InVivo halts trial of spine injury treatment after third patient dies American City Business Journals
08:00AM  InVivo Therapeutics Announces Updates on the INSPIRE Study Business Wire
Jul-12-17 08:00AM  InVivo Therapeutics Announces Stanford Medicine as New Site for INSPIRE Study Business Wire
Jul-11-17 08:00AM  InVivo Therapeutics Opens First Site in the United Kingdom for INSPIRE Study Business Wire
Jul-10-17 08:00AM  InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer Business Wire
Jun-29-17 08:00AM  InVivo Therapeutics Announces UCHealth Memorial Hospital as New Site for INSPIRE Study Business Wire
Jun-28-17 09:45AM  Wednesdays Biggest Early Market Movers 24/7 Wall St.
08:00AM  InVivo Therapeutics Announces Positive Motor Recovery Assessments in Two Patients in the INSPIRE Study of the Neuro-Spinal Scaffold Business Wire
Jun-27-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Thomas Jefferson University Hospital Business Wire
Jun-20-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Allegheny General Hospital Business Wire
Jun-12-17 08:00AM  InVivo Therapeutics to Present at JMP Securities Annual Life Sciences Conference Business Wire
Jun-01-17 08:00AM  InVivo Therapeutics Announces Posting of Management Presentation Recording from Annual Shareholders Meeting Business Wire
May-30-17 08:00AM  InVivo Therapeutics Announces Update to the Contemporary Thoracic SCI Registry Study (the CONTEMPO Registry Study) Business Wire
May-09-17 08:00AM  InVivo Therapeutics Announces Presentation at Combined Canadian Spinal Cord and Ontario Spinal Cord Injury Research Network Meeting Business Wire
May-08-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Oregon Health and Science University Business Wire
May-05-17 05:03AM  InVivo reports 1Q loss Associated Press
May-04-17 04:36PM  InVivo Therapeutics Provides Clinical Update and Reports 2017 First Quarter Financial Results Business Wire
Apr-20-17 08:00AM  InVivo Therapeutics Announces Oral Presentations at the 2017 American Spinal Injury Association Annual Scientific Meeting Business Wire
Apr-10-17 08:00AM  InVivo Therapeutics Announces New Site for INSPIRE Study Business Wire
Apr-05-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center Business Wire
08:00AM  InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center
Mar-31-17 04:04PM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-30-17 08:00AM  InVivo Therapeutics Announces First Canadian Site for Cervical Spinal Cord Injury Study Business Wire
Mar-29-17 08:00AM  InVivo Therapeutics Appoints Christopher McNulty as Chief Financial Officer Business Wire
Mar-28-17 08:00AM  InVivo Therapeutics Announces Seventh Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold Business Wire
Mar-27-17 08:00AM  InVivo Therapeutics to Present at Needham and Companys 16th Annual Healthcare Conference Business Wire
Mar-23-17 08:00AM  InVivo to Initiate Cervical Spinal Cord Injury Study Business Wire
Mar-21-17 08:00AM  InVivo Therapeutics Announces Submission to the FDA of Its Nonclinical Studies Module for the Neuro-Spinal Scaffold Business Wire
Mar-20-17 08:00AM  InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jerseys Cooper Neurological Institute Business Wire
Mar-16-17 01:04PM  INVIVO THERAPEUTICS HOLDINGS CORP. Financials
Mar-15-17 08:00AM  InVivo Therapeutics Receives Clinical Trial Application Approval from UK's Medicines Healthcare Products Regulatory Agency Business Wire
Mar-10-17 04:46PM  InVivo reports 4Q loss
04:30PM  InVivo Therapeutics Reports 2016 Year-end Financial Results and Business Update Business Wire
04:10PM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 10-K, Annual Report
Mar-09-17 08:00AM  InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at Keck Hospital, University of Southern California Business Wire
Mar-08-17 11:03AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating InVivo Therapeutics Holdings Corp. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Feb-28-17 08:00AM  InVivo Therapeutics to Present and Exhibit at Spine Summit 2017 Business Wire
Feb-27-17 08:00AM  InVivo Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference Business Wire
Feb-07-17 08:00AM  InVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference Business Wire
Jan-26-17 08:19AM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Regulation FD Disclosure
Jan-25-17 11:40AM  InVivo Gains on Neuro-Spinal Scaffold Results at Investopedia
Jan-24-17 01:18PM  Here's Why InVivo Therapeutics is Gaining Today
08:00AM  InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold Business Wire
Jan-23-17 04:10PM  SEC halts trading in PixarBio amid concerns over stock manipulation at bizjournals.com
Jan-19-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study Business Wire
Jan-18-17 08:00AM  InVivo Therapeutics Featured in Nationally Syndicated Radio Segment Business Wire
Jan-17-17 08:00AM  InVivo Therapeutics Announces University of New Mexico Hospital as New Site for INSPIRE Study Business Wire
Jan-10-17 08:00AM  InVivo Therapeutics Announces INSPIRES 29th Clinical Site: Rhode Island Hospital Business Wire
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. The company is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for the implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.